Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.64
CI's Cash to Debt is ranked lower than
64% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.36 vs. CI: 0.64 )
Ranked among companies with meaningful Cash to Debt only.
CI' s Cash to Debt Range Over the Past 10 Years
Min: 0.28  Med: 0.7 Max: N/A
Current: 0.64
Equity to Asset 0.23
CI's Equity to Asset is ranked lower than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.32 vs. CI: 0.23 )
Ranked among companies with meaningful Equity to Asset only.
CI' s Equity to Asset Range Over the Past 10 Years
Min: 0.05  Med: 0.12 Max: 0.23
Current: 0.23
0.05
0.23
Interest Coverage 12.13
CI's Interest Coverage is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.49 vs. CI: 12.13 )
Ranked among companies with meaningful Interest Coverage only.
CI' s Interest Coverage Range Over the Past 10 Years
Min: 8.06  Med: 11.95 Max: N/A
Current: 12.13
F-Score: 6
M-Score: -2.67
WACC vs ROIC
5.07%
12.63%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 7.73
CI's Operating margin (%) is ranked higher than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.16 vs. CI: 7.73 )
Ranked among companies with meaningful Operating margin (%) only.
CI' s Operating margin (%) Range Over the Past 10 Years
Min: 2  Med: 8.68 Max: 10.46
Current: 7.73
2
10.46
Net-margin (%) 4.87
CI's Net-margin (%) is ranked higher than
80% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.45 vs. CI: 4.87 )
Ranked among companies with meaningful Net-margin (%) only.
CI' s Net-margin (%) Range Over the Past 10 Years
Min: 1.53  Med: 5.89 Max: 7.07
Current: 4.87
1.53
7.07
ROE (%) 14.97
CI's ROE (%) is ranked higher than
70% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.62 vs. CI: 14.97 )
Ranked among companies with meaningful ROE (%) only.
CI' s ROE (%) Range Over the Past 10 Years
Min: 7  Med: 19.03 Max: 28.9
Current: 14.97
7
28.9
ROA (%) 3.26
CI's ROA (%) is ranked lower than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.81 vs. CI: 3.26 )
Ranked among companies with meaningful ROA (%) only.
CI' s ROA (%) Range Over the Past 10 Years
Min: 0.72  Med: 2.81 Max: 3.81
Current: 3.26
0.72
3.81
Revenue Growth (3Y)(%) 13.70
CI's Revenue Growth (3Y)(%) is ranked higher than
50% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.70 vs. CI: 13.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -2.2  Med: 10.8 Max: 18.4
Current: 13.7
-2.2
18.4
EBITDA Growth (3Y)(%) 12.50
CI's EBITDA Growth (3Y)(%) is ranked higher than
50% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.50 vs. CI: 12.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CI' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -24.3  Med: 9.6 Max: 57.7
Current: 12.5
-24.3
57.7
EPS Growth (3Y)(%) 12.70
CI's EPS Growth (3Y)(%) is ranked higher than
58% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.10 vs. CI: 12.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -32  Med: 6.2 Max: 64.6
Current: 12.7
-32
64.6
GuruFocus has detected 3 Warning Signs with Cigna Corp $CI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CI's 10-Y Financials

Financials (Next Earnings Date: 2017-02-02)


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

CI Guru Trades in Q4 2015

David Einhorn 375,000 sh (New)
Larry Robbins 6,995,201 sh (+52.21%)
NWQ Managers 442,272 sh (+47.63%)
Vanguard Health Care Fund 7,105,831 sh (+24.38%)
Jeremy Grantham 551,700 sh (+24.01%)
Lee Ainslie 5,540 sh (+14.23%)
Mario Gabelli 15,800 sh (+8.59%)
Dodge & Cox 13,515,865 sh (+4.94%)
Pioneer Investments 37,936 sh (+1.08%)
Mairs and Power 4,695 sh (unchged)
Keeley Asset Management Corp 6,530 sh (unchged)
David Dreman Sold Out
Leon Cooperman Sold Out
John Burbank Sold Out
Paul Tudor Jones Sold Out
Barrow, Hanley, Mewhinney & Strauss 2,477,958 sh (-0.96%)
Eric Mindich 951,602 sh (-15.97%)
Joel Greenblatt 55,671 sh (-19.01%)
Richard Pzena 1,278,327 sh (-32.11%)
Louis Moore Bacon 14,463 sh (-70.78%)
Jim Simons 25,300 sh (-88.11%)
» More
Q1 2016

CI Guru Trades in Q1 2016

John Hussman 25,000 sh (New)
David Dreman 200 sh (New)
Andreas Halvorsen 400,343 sh (New)
George Soros 26,000 sh (New)
Jim Simons 272,500 sh (+977.08%)
Keeley Asset Management Corp 11,550 sh (+76.88%)
Lee Ainslie 7,700 sh (+38.99%)
David Einhorn 435,000 sh (+16.00%)
Eric Mindich 983,522 sh (+3.35%)
Dodge & Cox 13,554,225 sh (+0.28%)
Barrow, Hanley, Mewhinney & Strauss 2,481,007 sh (+0.12%)
Mairs and Power 4,695 sh (unchged)
Vanguard Health Care Fund 7,105,831 sh (unchged)
Mario Gabelli 15,800 sh (unchged)
Louis Moore Bacon Sold Out
Joel Greenblatt 55,487 sh (-0.33%)
Signature Select Canadian Fund 14,100 sh (-3.42%)
NWQ Managers 422,351 sh (-4.50%)
Larry Robbins 6,095,014 sh (-12.87%)
Richard Pzena 761,695 sh (-40.41%)
Pioneer Investments 19,025 sh (-49.85%)
Jeremy Grantham 1,800 sh (-99.67%)
» More
Q2 2016

CI Guru Trades in Q2 2016

Paul Tudor Jones 3,900 sh (New)
Steven Cohen 143,700 sh (New)
John Paulson 61,800 sh (New)
Louis Moore Bacon 1,785 sh (New)
NWQ Managers 672,362 sh (+59.20%)
Jim Simons 401,700 sh (+47.41%)
David Dreman 283 sh (+41.50%)
Lee Ainslie 9,710 sh (+26.10%)
Andreas Halvorsen 501,208 sh (+25.19%)
Dodge & Cox 15,282,616 sh (+12.75%)
Keeley Asset Management Corp 12,880 sh (+11.52%)
Mairs and Power 4,801 sh (+2.26%)
Richard Pzena 771,405 sh (+1.27%)
Larry Robbins 6,106,123 sh (+0.18%)
Vanguard Health Care Fund 7,105,831 sh (unchged)
Eric Mindich 500,000 sh (unchged)
David Einhorn 435,000 sh (unchged)
John Hussman Sold Out
George Soros Sold Out
Jeremy Grantham Sold Out
Eric Mindich Sold Out
Pioneer Investments 18,887 sh (-0.73%)
Barrow, Hanley, Mewhinney & Strauss 2,375,427 sh (-4.26%)
Mario Gabelli 15,000 sh (-5.06%)
Joel Greenblatt 11,919 sh (-78.52%)
» More
Q3 2016

CI Guru Trades in Q3 2016

George Soros 13,000 sh (New)
Lee Ainslie 456,283 sh (+4599.10%)
Joel Greenblatt 18,684 sh (+56.76%)
Steven Cohen 193,000 sh (+34.31%)
Richard Pzena 906,125 sh (+17.46%)
Vanguard Health Care Fund 7,533,631 sh (+6.02%)
Mario Gabelli 15,000 sh (unchged)
Eric Mindich 500,000 sh (unchged)
David Dreman 283 sh (unchged)
Pioneer Investments 18,887 sh (unchged)
David Einhorn 435,000 sh (unchged)
Louis Moore Bacon Sold Out
Andreas Halvorsen Sold Out
Paul Tudor Jones Sold Out
John Paulson Sold Out
Signature Select Canadian Fund Sold Out
Jim Simons Sold Out
Keeley Asset Management Corp 12,730 sh (-1.16%)
Larry Robbins 5,991,396 sh (-1.88%)
Mairs and Power 4,695 sh (-2.21%)
Dodge & Cox 14,448,844 sh (-5.46%)
Barrow, Hanley, Mewhinney & Strauss 2,057,208 sh (-13.40%)
NWQ Managers 460,741 sh (-31.47%)
» More
» Details

Insider Trades

Latest Guru Trades with CI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:AET, NAS:ESRX, NYSE:HUM, NYSE:ANTX, NYSE:CNC, NYSE:WCG, NYSE:MOH, NAS:MGLN, OTCPK:QULRY, NYSE:UAM, NAS:HIIQ, NAS:CNXR, OTCPK:OPRX, OTCPK:WCUI, NYSE:CVS, NYSE:UNH » details
Traded in other countries:CGN.Germany,
Cigna Corp is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services.

Cigna Corp was incorporated in Delaware in 1981. The Company is a health services organization. It offers a differentiated set of medical, dental, disability, life and accident insurance and related products and services. The Company operates in four reportable segments Global Health Care; Global Supplemental Benefits; Group Disability and Life; Other Operations. The Global Health Care aggregates the Commercial and Government operating segments. The Commercial operating segment encompasses both the U.S. commercial and certain international health care businesses serving employers and their employees, other groups, and individuals. Products and services include medical, dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs and other products and services to insured and self-insured customers. The Government operating segment offers Medicare Advantage and Medicare Part D plans to seniors and Medicaid plans. Global Supplemental Benefits offers supplemental health, life and accident insurance products in selected international markets and in the U.S. Group Disability and Life provides group long-term and short-term disability, group life, accident and specialty insurance products and related services. The Other Operations segment includes the results from the run-off reinsurance and settlement annuity businesses, as well as the remaining deferred gains recognized from the sale of the individual life insurance and annuity and retirement benefits businesses. The Commercial operating segment, either directly or through its partners, offers some or all of its products in all 50 states, the District of Columbia, the U.S. Virgin Islands, Canada, Europe, the Middle East, and Asia. It offers a variety of medical plans including - Managed Care Plans including HMO, Network, Network Open Access and Open Access Plus; PPO Plans; and Choice Fund Suite of Consumer-Driven Products. Its government health plans includes Medicare Advantage; Medicare Part D; and Medicaid. The Company offers health care and related products and services in the following customer segments or markets - national; middle market; select, individual; government; and international. The Company's competitors in U.S.-based health care businesses include other national insurance and health services companies that provide group health and life insurance products; not for profit managed care organizations; other regional stand-alone managed care and specialty companies; managed care organizations affiliated with insurance companies and hospitals; and national managed pharmacy, behavioral health and utilization review services companies. Its competitors in the international health care business include U.S. and other health insurance companies with health benefits operations.

Top Ranked Articles about Cigna Corp

52-Week Company Lows Lows of 5 companies
According to the GuruFocus list of 52-week lows, these guru stocks have reached their 52-week lows. Read more...
5 Companies for Defensive Investors Near 52 Week Lows These companies were selected and reviewed by ModernGraham
Larry Robbins Continues to Invest in Acquisition Targets Robbins ups his stakes in healthcare and media mergers
Noted health care investor Larry Robbins (Trades, Portfolio) of Glenview Capital added to his stake in at least three companies that are currently the targets in mega mergers. All three deals are also under intense scrutiny from regulators. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 19.64
CI's P/E(ttm) is ranked higher than
50% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.85 vs. CI: 19.64 )
Ranked among companies with meaningful P/E(ttm) only.
CI' s P/E(ttm) Range Over the Past 10 Years
Min: 3.25  Med: 12.58 Max: 21.1
Current: 19.64
3.25
21.1
Forward P/E 15.22
CI's Forward P/E is ranked lower than
67% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.97 vs. CI: 15.22 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 19.64
CI's PE(NRI) is ranked higher than
50% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.85 vs. CI: 19.64 )
Ranked among companies with meaningful PE(NRI) only.
CI' s PE(NRI) Range Over the Past 10 Years
Min: 3.25  Med: 12.64 Max: 21.1
Current: 19.64
3.25
21.1
Price/Owner Earnings (ttm) 10.13
CI's Price/Owner Earnings (ttm) is ranked lower than
56% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.05 vs. CI: 10.13 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
CI' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 2.21  Med: 10.26 Max: 541.12
Current: 10.13
2.21
541.12
P/B 2.66
CI's P/B is ranked lower than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.43 vs. CI: 2.66 )
Ranked among companies with meaningful P/B only.
CI' s P/B Range Over the Past 10 Years
Min: 0.52  Med: 2.21 Max: 3.96
Current: 2.66
0.52
3.96
P/S 0.95
CI's P/S is ranked lower than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.51 vs. CI: 0.95 )
Ranked among companies with meaningful P/S only.
CI' s P/S Range Over the Past 10 Years
Min: 0.13  Med: 0.68 Max: 1.2
Current: 0.95
0.13
1.2
PFCF 10.77
CI's PFCF is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.03 vs. CI: 10.77 )
Ranked among companies with meaningful PFCF only.
CI' s PFCF Range Over the Past 10 Years
Min: 1.81  Med: 13.97 Max: 130.79
Current: 10.77
1.81
130.79
POCF 9.38
CI's POCF is ranked lower than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.61 vs. CI: 9.38 )
Ranked among companies with meaningful POCF only.
CI' s POCF Range Over the Past 10 Years
Min: 1.52  Med: 10.44 Max: 48.76
Current: 9.38
1.52
48.76
EV-to-EBIT 11.71
CI's EV-to-EBIT is ranked higher than
60% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.99 vs. CI: 11.71 )
Ranked among companies with meaningful EV-to-EBIT only.
CI' s EV-to-EBIT Range Over the Past 10 Years
Min: -2.6  Med: 8.1 Max: 18
Current: 11.71
-2.6
18
EV-to-EBITDA 9.92
CI's EV-to-EBITDA is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.13 vs. CI: 9.92 )
Ranked among companies with meaningful EV-to-EBITDA only.
CI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2.3  Med: 6.8 Max: 11.2
Current: 9.92
-2.3
11.2
PEG 1.26
CI's PEG is ranked higher than
67% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.36 vs. CI: 1.26 )
Ranked among companies with meaningful PEG only.
CI' s PEG Range Over the Past 10 Years
Min: 0.24  Med: 0.76 Max: 11.78
Current: 1.26
0.24
11.78
Shiller P/E 26.34
CI's Shiller P/E is ranked higher than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 26.62 vs. CI: 26.34 )
Ranked among companies with meaningful Shiller P/E only.
CI' s Shiller P/E Range Over the Past 10 Years
Min: 3.12  Med: 16.06 Max: 33.88
Current: 26.34
3.12
33.88

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.03
CI's Dividend Yield is ranked lower than
100% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.77 vs. CI: 0.03 )
Ranked among companies with meaningful Dividend Yield only.
CI' s Dividend Yield Range Over the Past 10 Years
Min: 0.02  Med: 0.08 Max: 0.57
Current: 0.03
0.02
0.57
Dividend Payout 0.01
CI's Dividend Payout is ranked higher than
92% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.30 vs. CI: 0.01 )
Ranked among companies with meaningful Dividend Payout only.
CI' s Dividend Payout Range Over the Past 10 Years
Min: 0.01  Med: 0.01 Max: 0.04
Current: 0.01
0.01
0.04
Forward Dividend Yield 0.03
CI's Forward Dividend Yield is ranked lower than
100% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.39 vs. CI: 0.03 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.03
CI's Yield on cost (5-Year) is ranked lower than
100% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.47 vs. CI: 0.03 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CI' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.02  Med: 0.08 Max: 0.57
Current: 0.03
0.02
0.57
3-Year Average Share Buyback Ratio 3.50
CI's 3-Year Average Share Buyback Ratio is ranked higher than
79% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.20 vs. CI: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5.8  Med: 4.6 Max: 11.7
Current: 3.5
-5.8
11.7

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.66
CI's Price/Tangible Book is ranked lower than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.10 vs. CI: 4.66 )
Ranked among companies with meaningful Price/Tangible Book only.
CI' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.46  Med: 4.2 Max: 28
Current: 4.66
1.46
28
Price/Projected FCF 1.04
CI's Price/Projected FCF is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. CI: 1.04 )
Ranked among companies with meaningful Price/Projected FCF only.
CI' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.29  Med: 0.84 Max: 4.89
Current: 1.04
0.29
4.89
Price/DCF (Earnings Based) 1.21
CI's Price/DCF (Earnings Based) is ranked higher than
56% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.22 vs. CI: 1.21 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.40
CI's Price/Median PS Value is ranked lower than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.09 vs. CI: 1.40 )
Ranked among companies with meaningful Price/Median PS Value only.
CI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.36  Med: 1.06 Max: 3.85
Current: 1.4
0.36
3.85
Price/Peter Lynch Fair Value 1.32
CI's Price/Peter Lynch Fair Value is ranked lower than
55% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.26 vs. CI: 1.32 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CI' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.35  Med: 0.61 Max: 2.96
Current: 1.32
0.35
2.96
Price/Graham Number 2.02
CI's Price/Graham Number is ranked higher than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.34 vs. CI: 2.02 )
Ranked among companies with meaningful Price/Graham Number only.
CI' s Price/Graham Number Range Over the Past 10 Years
Min: 0.85  Med: 1.62 Max: 3.75
Current: 2.02
0.85
3.75
Earnings Yield (Greenblatt) (%) 8.50
CI's Earnings Yield (Greenblatt) (%) is ranked higher than
67% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.10 vs. CI: 8.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 5.6  Med: 12.1 Max: 50506.3
Current: 8.5
5.6
50506.3
Forward Rate of Return (Yacktman) (%) 19.39
CI's Forward Rate of Return (Yacktman) (%) is ranked higher than
60% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.15 vs. CI: 19.39 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2.1  Med: 19.3 Max: 50.9
Current: 19.39
-2.1
50.9

More Statistics

Revenue (TTM) (Mil) $39,252
EPS (TTM) $ 7.37
Beta0.39
Short Percentage of Float0.63%
52-Week Range $115.03 - 148.99
Shares Outstanding (Mil)256.74

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 39,126 40,232 43,075
EPS ($) 8.39 9.64 10.64
EPS w/o NRI ($) 8.39 9.64 10.64
EPS Growth Rate
(3Y to 5Y Estimate)
8.63%
Dividends Per Share ($) 0.02 0.02
» More Articles for CI

Headlines

Articles On GuruFocus.com
5 Undervalued Companies With a Low Beta Dec 12 2016 
52-Week Company Lows Sep 15 2016 
Dodge & Cox Exits Time Warner Cable, Buys MetLife Sep 12 2016 
52-Week Company Lows Sep 08 2016 
5 Undervalued Companies Near 52 Week Lows Sep 02 2016 
52-Week Company Lows Aug 03 2016 
5 Undervalued Companies With a Low Beta Aug 03 2016 
5 Companies for Defensive Investors Near 52 Week Lows Aug 02 2016 
Cigna Is An Excellent Prospect, Regardless of Anthem Deal Jul 17 2016 
9 Best Stocks for Value Investors This Week Jul 13 2016 

More From Other Websites
Judge to block mega-merger of Anthem and Cigna: NY Post Jan 19 2017
Judge to block mega-merger of Anthem and Cigna - NY Post Jan 19 2017
Insurers' Shares Drop After Cigna's Sour Response to Merger Extension Jan 19 2017
Anthem extends Cigna deal closing date ahead of court ruling Jan 19 2017
CIGNA CORP Files SEC form 8-K, Other Events Jan 19 2017
Biotech Premarket Movers: SGMO, IPXL, PTLA Jan 13 2017
Blog Coverage Expensive EpiPen Proves Costly for Mylan as Cigna Drops it from Coverage List; Opts... Jan 13 2017
Business Watch Jan 13 2017
Mylan Crushed by Trump, Cigna and CVS -- All In Two Days Jan 12 2017
[$$] Cigna Drops EpiPen Coverage for Generic Jan 12 2017
CVS Is the Latest to Rock Mylan's EpiPen Empire Jan 12 2017
Cigna Will No Longer Cover Mylan's EpiPen Jan 12 2017
Cigna Defends Abandoning EpiPen Coverage Jan 12 2017
Mylan's EpiPen Dropped From Cigna's Coverage List Jan 11 2017
Cigna and Scripps Health Form Alliance to Deliver Innovative Health Plans in San Diego Jan 11 2017
Health Insurers Are Riding High -- Which Should You Buy? Jan 11 2017
CIGNA CORP Files SEC form 8-K, Regulation FD Disclosure Jan 10 2017
Cigna Corporation’s Fourth Quarter 2016 Earnings Release Details Jan 09 2017
Cigna Corporation Announces Appearance at the 35th Annual J.P. Morgan Healthcare Conference Jan 04 2017
Coverage initiated on CIGNA by Piper Jaffray Jan 04 2017
Cigna Hong Kong Launches HealthSecure Protection Booster Jan 03 2017
January To See Anthem-Cigna Merger Fate Decided Dec 29 2016
Health Care Uncertainty in a Trump Presidency Dec 29 2016
Cigna Launches One Guide – Simplified, Personalized Service to Help Choose a Health Plan, Improve... Dec 01 2016
Cigna Encourages Medical Practices to Sign Opioid Pledge Nov 18 2016
Cigna, Northwest Indiana’s Community Healthcare System Form New Collaborative Care Relationship Nov 16 2016
With Sights, Sounds, Services and VR Cigna Creates 21st Century Healthy Workplace Nov 15 2016
Los Barrios Unidos Clinic Opens in Dallas; Asthma Program at Clinic Made Possible by Cigna... Nov 10 2016
Cigna Reports Third Quarter 2016 Results Led by Strong Commercial Health Care Performance Nov 03 2016
Cigna Foundation Announces Grants to Help Improve Health in Wyoming Oct 31 2016
Cigna, Cigna Foundation and Cordani Foundation Partner To Bring More Health Resources to Communities... Oct 26 2016
Blessings in a Backpack, Cigna Foundation and Cigna Provide Weekend Meals to Mission Ridge... Oct 20 2016
Cigna, UNC Health Alliance Collaborate to Offer Cigna Individual and Family Plans in Raleigh Area Oct 20 2016
Cigna to Offer Individual and Family Plans in Chicago Area Oct 19 2016
UNC Health Alliance and Cigna Collaborate to Improve Health and Value in North Carolina Oct 18 2016
Cigna Corporation’s Third Quarter 2016 Earnings Release Details Oct 05 2016
NYUPN CLINICALLY INTEGRATED NETWORK and Cigna program aims to improve care for people receiving... Oct 05 2016
Cigna Telehealth Connection Expands Access and Choice to Millions, Including Adding Access to... Sep 27 2016
Cigna Foundation Workplace Wellness Summit Set for Oct. 11 in Dubai; Leading Dubai Employers to... Sep 26 2016
Cigna Recognizes Lena Pope for Commitment to Employee Health and Wellness Sep 15 2016
Cigna Recognizes Premier Inc for Commitment to Employee Health and Wellness Sep 15 2016
Cigna Foundation Announces New Community Health Navigation Grants Sep 14 2016
U.S. judge in Anthem merger trial sets trial for November 21, plans ruling by late January 2017 Aug 12 2016
U.S. moves to block massive health insurer deals led by Anthem, Aetna Jul 21 2016
U.S. moves to block massive health insurer deals led by Anthem, Aetna Jul 21 2016
U.S. moves to block massive health insurer deals led by Anthem, Aetna Jul 21 2016
US acts to block two mega-mergers in health insurance Jul 21 2016
US readies suits to block large health mergers: source Jul 19 2016
U.S. antitrust officials set to challenge Anthem, Aetna deals - source Jul 19 2016
Exclusive - Analysis suggests Anthem deal could raise health costs Jun 23 2016
Antitrust regulators worry about proposed Cigna-Anthem merger - WSJ Jun 19 2016
Cigna Global Health Benefits appoints Neil Irwin as Head of Global Distribution Jun 10 2016
Doubts mount over merger of health insurers Anthem, Cigna May 23 2016
Cognizant forecasts slowest revenue growth in 14 years Feb 08 2016
Cigna CEO defends Anthem deal, says consumer will still have choice Sep 17 2015
US STOCKS-Futures little changed as investors await GDP data Jul 30 2015
Anthem to buy Cigna, creating biggest U.S. health insurer Jul 24 2015
Anthem locks in bank financing for Cigna purchase Jul 24 2015
Anthem locks in bank financing for Cigna purchase Jul 24 2015
Health insurer Anthem to buy Cigna in $54.2 bln deal Jul 24 2015
Health insurer Anthem to buy Cigna in $54.2 bln deal Jul 24 2015
US health insurer Anthem agrees to buy Cigna in $54.2bn deal Jul 23 2015
Anthem set to announce deal for Cigna this week - sources Jul 22 2015
Anthem set to announce deal for Cigna this week - sources Jul 22 2015
Anthem set to announce deal for Cigna this week - sources Jul 22 2015
Anthem set to announce deal for Cigna this week - ssource Jul 22 2015
Health insurer Anthem nears $48 billion deal to buy Cigna - WSJ Jul 22 2015
Health insurer Anthem nears $48 billion deal to buy Cigna - WSJ Jul 22 2015
MOVES-Bupa Global names Sheldon Kenton as global commercial director Jul 07 2015
Aetna CEO addresses antitrust concerns over Humana deal Jul 06 2015
US stocks fall after Greek vote Jul 06 2015
US stocks drop after Greek vote Jul 06 2015
US stocks down about 0.6% after Greek vote Jul 06 2015
Aetna’s Humana deal to bring scrutiny on other insurer tie-ups - experts Jul 03 2015
Anthem, Cigna in new round of talks - source Jul 02 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)